• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLC121000
Medical Device Problem Code Device Endoleak (4074)
Health Effect - Clinical Codes Aneurysm expansion (4597); Clinical Endoleak (4843)
Date of Event 11/01/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H6: code c21 - results pending determination and completion of investigations.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.As it is unknown which device is directly implicated in this endoleak event, the following devices will also be included in this report: catalog #pll161207 / serial #(b)(6) / udi # (b)(4) catalog #pll161407 / serial #(b)(6) / udi #(b)(4).
 
Event or Problem Description
On (b)(6) 2021, the patient underwent an endovascular procedure to treat an abdominal aortic aneurysm (aaa) utilizing gore® excluder® aaa endoprosthesis devices (rlt261412, pll161407, pll161207, and plc121000).On an unknown date in (b)(6) 2025, a type 1b endoleak was observed in the patient's left iliac artery through imaging and a reintervention was planned.It is unknown whether the endoleak was associated with the pll161407, pll161207, or plc121000.The cause of the endoleak is unknown.The endoleak led to aneurysm enlargement; however, growth amount is unknown.On (b)(6) 2026, the patient underwent a reintervention procedure to treat the type 1b endoleak utilizing a pll161007.The patient's left hypogastric artery was embolized.The endoleak was resolved.The patient tolerated the procedure.
 
Additional Manufacturer Narrative
Added g3/g4, h1/h2, h6.Additional information: removed b21 type of investigation not yet determined and added b14 analysis of production records, b13 communication/interviews, and b20 device not accessible for testing.Removed c21 results pending completion of investigation and added c19 no device problem found and c20 no findings available.Removed d16 conclusion not yet available and added d15 cause not established and d12 known inherent risk of device.H6: code c19 - a review of the manufacturing records indicated the lot met all pre-release specifications.H6: code c20 - the device remains implanted and, therefore, was not available for direct analysis by gore.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
brianna zipprich
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key23994742
Report Number3013164176-2026-02865
Device Sequence Number18741555
Product Code MIH
UDI-Device Identifier00733132618613
UDI-Public(01)00733132618613(17)220328
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/12/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/28/2022
Device Catalogue NumberPLC121000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/01/2025
Supplement Date Received by Manufacturer01/12/2026
Initial Report FDA Received Date01/07/2026
Supplement Report FDA Received Date01/12/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/29/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age80 YR
Patient SexMale
Patient Weight71 KG
-
-